Latest Baseimmune News & Updates

Baseimmune hires Scientist – Protein Expression and Purification in London

The vacancy seeks protein expression and purification expertise in the London area, encouraging qualified candidates to apply and colleagues to share.

Baseimmune announces leadership updates and strategic focus

Joshua Blight is appointed Chief Scientific Officer, guiding scientific strategy and the antigen-design platform. Kevin Walton is appointed Chief Executive Officer, leading expansion into chronic diseases and multi-pathway biology.

Baseimmune announces Ariane steps down as CSO

Since 2019, she helped establish a robust immunotherapy platform and supported multiple funding rounds.

Baseimmune is hiring a DevOps Engineer in the UK

The company is looking for candidates to apply or share the opportunity within their network.

Baseimmune expands into fibrosis

Baseimmune Ltd. has announced its strategic expansion into fibrosis, with a new fibrosis-focused pipeline led by a program for idiopathic pulmonary fibrosis (IPF). The company's...

Baseimmune Raises $11.3M in Series A funding to Develop Better Vaccines ...

– New investors MSD Global Health Innovation Fund and IQ Capital co-led Series A with existing investors participating – AI-based design algorithm shortens the time...

London based Baseimmune shows BiotechTV the new space it moved into in LBIC's Apex Building in Kings Cross where it will use its AI platform to discover and develop new vaccines

Co-founder & CEO Joshua Blight talks about Baseimmune's platform, which was inspired by the work that happened during COVID both in the UK and abroad...

Baseimmune launches for AI-based vaccine development